blog
Video on Helminth Therapy
The video below is an excellent 5 minute overview of helminth therapy produced and created by Asphelia Pharmaceuticals.
Upcoming Events
Mount Sinai School of Medicine - December 2009
Clinical Trial of TSO for Autism Recruiting
http://clinicaltrials.gov/ct2/show/NCT01040221
This will be a 16 week, open-label trial of TSO to assess the effect on repetitive behaviors, aggression and irritability, and global functioning in adults with autistic disorder. The objectives of the proposed study are to develop an innovative treatment approach to autism by 1) assessing the safety and efficacy of TSO treatment using behavioral and laboratory outcome measures; 2) determining whether this treatment has sufficient promise to warrant consideration of a larger, multi-centered, placebo-controlled clinical trial; 3) conducting secondary analyses to explore the relationship between clinical features, immune mechanisms, and treatment response.
Recent Blog Posts
06/21/2010
OCD Immune link
OCD behavior in mice has been linked to the Hoxb8 gene. Hoxb8 is found in … read more >
06/21/2010
Article about TSO therapy in BusinessWeek
This article about helminth and TSO therapy appeared recently in BusinessWeek (Now Bloomberg BusinessWeek) magazine. … read more >
09/23/2009
Major TSO Allergy Study in Press
A major double-blind, placebo controlled study of TSO therapy for allergic rhinitis is complete and … read more >
08/05/2009
Comments
There are currently no comments for this post